Acasti Pharma's stock was trading at $0.3849 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). View our full suite of financial calendars and market data tables, all for free. View Acasti Pharma's Short Interest. Earnings for Acasti Pharma are expected to grow in the coming year, from ($0.20) to ($0.18) per share.

Acasti Pharma has a P/B Ratio of 1.53. Here’s How To Know. Acasti Pharma, Inc. real time quote is equal to 0.184 USD at 2020-11-02, but your current investment may be devalued in the future. Policy, Acasti Pharma, Inc. Stock Price Forecast for 2020, Acasti Pharma, Inc. Stock Price Forecast for 2021, Acasti Pharma, Inc. Stock Price Forecast for 2022, Acasti Pharma, Inc. Stock Price Forecast for 2023, Acasti Pharma, Inc. Stock Price Forecast for 2024, Acasti Pharma, Inc. Stock Price Forecast for 2025. Learn more. Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. In that case, then, we find that the current price level is +980.95% off the targeted high while a plunge would see the stock lose 19.05% from current levels. Get daily stock ideas top-performing Wall Street analysts.

The 3-month trading volume is 6.07 Million shares. Want to see which stocks are moving? Our vendor, Zacks Investment Research, might revise this date in the … See what's happening in the market right now with MarketBeat's real-time news feed.

If you are looking for stocks with good return, Acasti Pharma, Inc. stock can be a bad, high-risk 1-year investment option. Looking for new stock ideas? The Acasti Pharma stock fell by -2.10% on the last day (Friday, 6th Nov 2020) from $0.19 to $0.18. All rights reserved.

Identify the most profitable chart patterns in seconds! You may vote once every thirty days.

Acasti Pharma, Inc. finance tips, On average, they anticipate Acasti Pharma's stock price to reach $2.81 in the next twelve months.

Acasti Pharma's management team includes the following people: Rookies Doubled Their Money In 2 Days with This New Strategy. He realized he could follow along - and take a slice of the profit. According to our analysis, this can happen.

Sign in, Not a member? bad, high-risk 1-year investment option.

Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed.

Anavex Life Sciences Corp. (NASDAQ:AVXL) up 22.09% over the past 30 days: Any Troubles Ahead?

Acasti Pharma, Inc. technical analysis,

The ACST stock price is -1366.67% off its 52-week high price of $3.08 and 14.29% above the 52-week low of $0.18.

Earnings growth for 2020 is a modest +30.3%. Short interest in the company has seen 1.09 Million shares shorted with days to … The P/E ratio of Acasti Pharma is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

None have rated the stock as Underweight. The biopharmaceutical company earns $-25,510,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis. View which stocks have been most impacted by COVID-19.

greenie453 — Please log in to your account or sign up in order to add this asset to your watchlist. The Acasti Pharma stock price is

Vote “Outperform” if you believe ACST will outperform the S&P 500 over the long term. change will be

According to analysts' consensus price target of $2.81, Acasti Pharma has a forecasted upside of 1,213.1% from its current price of $0.21.

Is Abercrombie & Fitch Co. (NYSE:ANF) Expensive At $18.07? 7chase7 — Year-to-date, Acasti Pharma Inc. shares have moved -91.43%, while the 5-day performance has seen it change 0.96%. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. In the past three months, Acasti Pharma insiders have not sold or bought any company stock.